"Northwestern Medicine is proud to have five hospitals ranked among “America’s Best” by U.S. News & World Report, 2021-22. Anchored by Northwestern Memorial Hospital, the #1 hospital in Illinois and a top 10 hospital in the nation, we’re leading the quest for better care and better treatments in the Chicagoland area. With more than 200 locations across Chicagoland, better care and better treatments are never far from home. To learn more, visit our website."

During the past decade, Northwestern University, Department of Neurology, conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwestern University, Department of Neurology," #1 collaborator was "Elan Pharmaceuticals" with 1 trials as a collaborator, "H. Lundbeck A/S" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "The Parkinson Study Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Northwestern University, Department of Neurology," are "Amyotrophic Lateral Sclerosis" (1 trials), "Fatigue" (1 trials), "Lou Gehrig's Disease" (1 trials), "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Northwestern University, Department of Neurology," in a lesser frequency.

Most popular intervention types in "Northwestern University, Department of Neurology," are "Drug" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Auto-titration CPAP" (1 trials), "CEP-1347 10mg" (1 trials), "CEP-1347 50mg" (1 trials) and "CEP1347 25mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwestern University, Department of Neurology," are 4 trials for "All" genders.

Currently, there are NaN active trials in "Northwestern University, Department of Neurology,". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Northwestern University, Department of Neurology,, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northwestern University, Department of Neurology,, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".